BI 605906
Modify Date: 2026-07-09 18:33:21
BI 605906 structure
|
Common Name | BI 605906 | ||
|---|---|---|---|---|
| CAS Number | 960293-88-3 | Molecular Weight | 432.50800 | |
| Density | 1.48±0.1 g/cm3 (20 °C, 760 mmHg) | Boiling Point | 713.7±60.0 °C (760 mmHg) | |
| Molecular Formula | C17H22F2N4O3S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BI 605906BI605906 is a novel IKKβ inhibitor with an IC50 value of 380 nM when assayed at 0.1 mM ATP. |
| Name | Thieno[2,3-b]pyridine-2-carboxamide, 3-amino-4-(1,1-difluoropropyl)-6-[4-(methylsulfonyl)-1-piperidinyl] |
|---|---|
| Synonym | More Synonyms |
| Description | BI605906 is a novel IKKβ inhibitor with an IC50 value of 380 nM when assayed at 0.1 mM ATP. |
|---|---|
| Related Catalog | |
| Target |
IKKβ:380 nM (IC50, at 0.1 mM ATP) |
| In Vitro | BI605906 is an inhibitor of IKKβ with improved selectivity. BI605906 inhibits IKKβ in vitro with an IC50 value of 380 nM when assayed at 0.1 mM ATP. The only other protein kinase that is inhibited of over 100 tested, which include IKKα, IKKε and TBK1, is the insulin-like growth factor 1 (IGF1) receptor (IC50=7.6 μM). BI605906 partially inhibits the IL-1-stimulated activation of IKKε/TBK1[1]. In primary mouse hepatocytes, Metformin treatment for 3 hours suppresses TNFα-induced degradation of the NF-κB negative regulator IκB, while modulating AMPK and MTOR signaling in a dose-dependent manner. The magnitude of the effect on IκB is comparable with BI605906. Unlike Metformin, BI605906 (10 μM ) does not suppress signaling downstream of mTOR nor does it activate AMPK. TNF-α-dependent expression of CINC-1/CXCL1, CXCL2, IL-1β, and IL-6 is strongly inhibited by both Metformin and BI605906 (10 μM)[2]. |
| Cell Assay | Primary hepatocytes are incubated in serum-free medium overnight and then stimulated for 3 h with or without 2 mM Metformin and TNF-α. In addition, cells are incubated with/without 10 μM BI605906 or 100 nM Rapamycin, before lysis and immunoblotting[2]. |
| References |
| Density | 1.48±0.1 g/cm3 (20 °C, 760 mmHg) |
|---|---|
| Boiling Point | 713.7±60.0 °C (760 mmHg) |
| Molecular Formula | C17H22F2N4O3S2 |
| Molecular Weight | 432.50800 |
| Exact Mass | 432.11000 |
| PSA | 156.00000 |
| LogP | 4.91990 |
| InChIKey | IYHHRZBKXXKDDY-UHFFFAOYSA-N |
| SMILES | CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12 |
| Storage condition | 2-8℃ |
|
Name: Thermal Shift Assay. Domain: start/stop: E122-S403
Source: ChEMBL
Target: Aurora kinase A
External Id: CHEMBL5067447
|
|
Name: Incucyte cell viability with human fibroblast
Source: ChEMBL
Target: Fibroblast
External Id: CHEMBL4725213
|
|
Name: Incucyte cell viability with HEK293T
Source: ChEMBL
Target: HEK-293T
External Id: CHEMBL4725212
|
|
Name: Human inhibitor of nuclear factor kappa B kinase subunit beta (IKK family)
Source: IUPHAR-DB
Target: inhibitor of nuclear factor kappa B kinase subunit beta (IKK family) [Homo sapiens]
External Id: 2039_Human
|
|
Name: Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VER...
Source: ChEMBL
Target: Severe acute respiratory syndrome coronavirus 2
External Id: CHEMBL4513082
|
|
Name: Thermal Shift Assay. Domain: start/stop: M1-S360
Source: ChEMBL
Target: Mitogen-activated protein kinase 1
External Id: CHEMBL5066518
|
|
Name: This assay model using primary human hepatocyte (PHH) spheroids, which are cultured i...
Source: ChEMBL
Target: Hepatocyte spheroids
External Id: CHEMBL5608110
|
|
Name: Targeting of F14 CAF-induced therapy resistance in O14 CRC organoid-stroma co-culture...
Source: ChEMBL
Target: Colon cancer organoid
External Id: CHEMBL5608114
|
|
Name: Targeting of F14 CAF-induced therapy resistance in O14 CRC organoid-stroma co-culture...
Source: ChEMBL
Target: Colon cancer organoid
External Id: CHEMBL5608115
|
Total 387, Current Page 1 of 39
1
2
3
4
5
| 3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide |
| BI605906 |